Market Research Blog – Page 1180 – New Product Development

Automated Cell Culture Systems Market Expected to Reach USD 20.87 Billion by 2030

The automated cell culture systems market is on track for significant expansion, with projections indicating a substantial increase from an estimated valuation of USD 10.91 billion in 2022 to approximately USD 20.87 billion by 2030. This growth is expected to occur at a robust compound annual growth rate (CAGR) of 8.4%.

Automated cell culture systems currently hold a substantial 44.5% share of the global cell culture market, reflecting their pivotal role in advancing biological research and pharmaceutical development. The expansion of this market is being driven by several key factors, including rising investment in stem cell research and development, recent drug breakthroughs, and increased funding towards the development of innovative cell culture technologies.

The surge in demand for automated systems is attributed to their ability to enhance efficiency, reproducibility, and scalability in cell culture processes. These advancements are critical for accelerating research and development efforts, particularly in the fields of drug discovery and regenerative medicine.

Besides, 3D cell cultures, which were cumbersome and costly earlier, have become feasible, owing to advent of spheroids. Also, they imitate tumors better due to hypoxic core and presence of nutrient gradient.

Researchers in the US and Germany have come up with a protocol to grow 3D cultures of generally used cancer cells to facilitate drug screenings. These factors will continue to put North America and Europe at the top pedestal in the automated cell culture systems market.

Further, the requirement of cell lines for devising vaccines against COVID-19 infection will augur well for the automated cell culture market despite the pandemic-induced economic downturn.

Automated Cell Culture Systems Market Outlook & Key Findings

Automated cell culture systems market is expected to witness a CAGR of 8% through 2030
Growing applications of cell lines in drug discovery to be a key growth driver
Consumables hold more than 60% of market value owing to ever-increasing research in stem cells and oncology
North America to capture more than 40% of market value and is expected to witness a CAGR of 6% through 2030
Biotech companies to remain prominent end users throughout the forecast period

Key Takeaways from the Automated Cell Culture Systems Market

Consumables are expected to reach US$ 11 Bn by 2030
Academic institutes are expected to take greater interest in research related to cell culture over the forecast period due to increased government funding in developed countries
North America and Europe collectively accounted for more than 60% of market share in 2019
Infinite cell line cultures held close to 75% of market share in 2019

“Advancements in technology, coupled with large-scale applications in cell-based drug delivery and drug discovery, are projected to drive the global automated cell culture systems market” – says the FMI analyst.

A Old Full Report Analysis Click Here

Key Segments of Automated Cell Culture Systems Industry Survey

Automated Cell Culture Systems Market by Product:

Automated Cell Culture Storage Equipment
Automated Cell Culture Vessels
Bioreactors
Consumables

Automated Cell Culture Systems Market by Cell Culture:

Finite Cell Line Cultures
Infinite Cell Line Cultures

Automated Cell Culture Systems Market by Application:

Drug Development
Stem Cell Research
Regenerative Medicine
Cancer Research

Automated Cell Culture Systems Market by End User:

Biotech Companies
Research Organizations
Academic Institutes

Automated Cell Culture Systems Market by Region:

North America Automated Cell Culture Systems Market
Latin America Automated Cell Culture Systems Market
Europe Automated Cell Culture Systems Market
East Asia Automated Cell Culture Systems Market
South Asia & Pacific Automated Cell Culture Systems Market
Middle East & Africa (MEA) Automated Cell Culture Systems Market

Automated Cell Culture Systems Market: Competitive Insights

The global automated cell culture systems market is set to expand its scope in the forecast period, stimulated by increasing drug discovery research and diverse applications of cell lines in research purposes. Furthermore, automated cell culture systems are used for experiments in drug discovery research and in cell banking process. In addition, cost effectiveness and rise in alternative methods for traditional cell culture production is augmenting the adoption of automated cell culture systems.

Key market players covered in the market include Thermo Fisher Scientific, Corning Incorporated, Merck KGaA, Lonza, Sartorius AG, Tecan Trading AG, Hamilton Medical AG., Biospherix and Promocell GmbH. Key players integrate their positions through acquisitions, mergers and new product launches.

Want more insights?

The study provides compelling insights on automated cell culture systems market on basis of product type (automated cell culture storage equipment, automated cell culture vessels, bioreactors and consumables), cell culture type (finite cell line cultures, infinite cell line cultures), application (drug development, stem cell research, regenerative medicine and cancer research) and end user (biotech companies, research organizations, academic institutes), and across seven major regions.

Author by

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Oligonucleotide API Market Projected to Reach USD 4.84 Billion by 2034 at a 5.60% of CAGR

The global oligonucleotide API market is poised for substantial growth, driven by increasing demand for new drug classes. According to recent projections, the market is expected to rise at a robust compound annual growth rate (CAGR) of 5.60% from 2024 to 2034. The market, valued at approximately USD 2.81 billion in 2024, is forecasted to expand to USD 4.84 billion by the end of 2034.

This anticipated growth is fueled by the growing need for advanced therapeutic options and the development of innovative drug classes that utilize oligonucleotide APIs. The surge in research and development activities, coupled with the rising prevalence of genetic and chronic diseases, is expected to drive demand for these specialized APIs.

The market’s expansion underscores the increasing importance of oligonucleotide APIs in drug development and their pivotal role in advancing personalized medicine. As the industry evolves, stakeholders, pharmaceutical companies, and investors are presented with significant opportunities in this dynamic sector.

Apart from immune therapy, microbial and cardiovascular infections, and cancer, oligonucleotide APIs are being tried out to treat neurological disorders like Alzheimer’s as well. However, factors like regulatory complexities and timely delivery of oligonucleotides (amidst COVID-19) are acting as restraints.

Key Takeaways from Global Oligonucleotide API Industry Study

Antisense oligonucleotide APIs are anticipated to reach US$ 4 Bn by 2030.
North America and Europe collectively accounted for more than 47% of revenue share in 2019 while Asia Pacific is expected to grow at the fastest rate in the forecast period.
Increase in the use of antisense oligonucleotide APIs (especially post-approval from the US FDA in 2016) to boost the market in the forecast period

“Inorganic mode of growth coupled with broad therapeutic applications in gene therapy is expected to bolster the Global Oligonucleotide API Industry,” says Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.).

New Product Launches: Key Indicators to Global Oligonucleotide API Industry

FMI has analyzed players such as Akcea Therapeutics, Biogen, Sarepta Therapeutics, Jazz Pharmaceuticals, Inc., Alnylam Pharmaceuticals, Inc., and Dynavax Technologies in this report. According to the analysis, these players are consolidating their positions through new product launches.

For instance –

In March 2020, Dynavax entered into a collaboration with Clover Biopharmaceuticals to develop a vaccine candidate to combat COVID-19. Clover is into advanced evaluation of its Covid-19 S-Trimer, protein-based coronavirus vaccine candidate and Dynavax has its technical expertise along with proprietary toll-like receptor 9 (TLR9) agonist adjuvant, CpG 1018 for executing this.
Alnylam Pharmaceuticals, Inc., in 2018, launched Givlaari and Onpattro at the commercial level.

Gene Therapy and Oligonucleotide APIs

Synthetic oligonucleotides are being used in gene therapy for inactivating genes that help in propagating the disease. Antisense oligonucleotide APIs are used for disrupting the faulty gene’s transcription.

Also, siRNA could be used for signaling the cell to disrupt faulty mRNA’s translation. Along these lines, Pharmamar, in Jan 2020, signed an agreement with Jazz Pharmaceuticals to sell the API for “lurbinectedin”, one of the late-phase treatments for SCLC (small cell lung cancer) so that the latter could commercialize it.

A Old Full Report Analysis Click Here

Key Segments of Oligonucleotide API Industry Survey:

Global Oligonucleotide API Industry by API:

Antisense Oligonucleotides APIs
Short Interfering RNA (siRNA) APIs
Phosphorodiamidate Morpholino Oligonucleotides (PMO) APIs
MiRNA APIs
Aptamers APIs
CpG Oligonucleotides APIs
Others (ON Conjugates (NP), ShRNA, etc.)

Global Oligonucleotide API Industry by Marketing Status:

Marketed
Clinical Trials (Clinical Phases)

Global Oligonucleotide API Industry by End User:

Contract Manufacturing Organizations (CMOs)
Pharmaceutical Companies
Biopharmaceutical Companies
Contract Development & Manufacturing Organizations (CDMOs)

Global Oligonucleotide API Industry by Region:

North America Oligonucleotide API Market
Latin America Oligonucleotide API Market
Europe Oligonucleotide API Market
East Asia Oligonucleotide API Market
South Asia & Pacific Oligonucleotide API Market
Middle East & Africa (MEA) Oligonucleotide API Market

Key Companies Profiled:

Jazz Pharmaceuticals, Inc.
Sarepta Therapeutics
Biogen
Dynavax Technologies
Akcea Therapeutics.
Alnylam Pharmaceuticals, Inc.

Author

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Injectable Benzodiazepine Market Set to Achieve USD 356 Million by 2032 with a Noteworthy 2.7% CAGR | FMI

The Global Injectable Benzodiazepine Industry are predicted to reach USD 274 million by the end of 2022. Sales of injectable benzodiazepines are predicted to reach USD 356 million by 2032’s end. From 2022 to 2032, the injectable benzodiazepines market is anticipated to expand at a 2.7% CAGR.

Global Injectable Benzodiazepine Industry sales are set to reach USD 260 million in 2020, as COVID-19 panic and uncertainty have set in, even among populations with no previous history of mental illnesses, according to a new study by Future Market Insights (FMI). The market research firm estimates the market to grow at 2.7% CAGR through 2030.

Although COVID-19 will create a short-term spike, in the long run, the market is likely to be driven by increasing demand for generic drugs. Growing acceptance of injectables as a route of administration is also likely to drive growth.

Key Takeaways of Global Injectable Benzodiazepine Industry Study

Lorazepam injectable benzodiazepine accounted for the highest share in the injectable benzodiazepine market in 2019
Seizures and anxiety are among the leading ailments where injectable benzodiazepines are administered
North America and Europe are expected to hold a noteworthy revenue share of about 60% in the Global Injectable Benzodiazepine Industry in 2020

Low-cost manufacturing and large patient pools in Asian countries are expected to be a key growth driver in the forecast period

“Growing incidences of seizures and anxiety followed by demand for generics to boost the Global Injectable Benzodiazepine Industry,” says an FMI Analyst.

Research Collaborations: Key to Sustenance

The market players are emphasizing expanding their manufacturing facilities with the introduction of cost-effective and generic drugs and also venturing into strategic partnerships.

In Jan 2020, Hospital Sales Force from Xellia signed an agreement with Eton to promote Biorphen in institutions that prefer having ready-to-use injectable formulations
In Oct 2019, KemPharm’s APADAZ (to treat ADHD) got licensed to KVK-Tech, Inc. to make its generic AG-APADAZ available all across the US
In Dec 2018, Hikma Pharmaceuticals came up with clobazam oral suspension as well as tablets, the generic equivalent to “Onfi” (marketed by H. Lundbeck A/S)

What else is in the report?

Future market insights offer a unique perspective and actionable insights on the Global Injectable Benzodiazepine Industry in its latest study, presenting historical demand assessment from 2015 – 2019 and projections from 2020–2030 based on drug class (diazepam, lorazepam, and midazolam), by the time of action (short-acting long-acting), by indication (agitation & aggression, anxiety, alcohol withdrawal, muscle spasm, seizures, tetanus, sedation, anesthesia insomnia, and status epilepticus), by distribution channel (hospital pharmacies, retail pharmacies, and online pharmacies) in seven key regions.

A Old Full Report Analysis Click Here

Key Segments of the Global Injectable Benzodiazepine Industry

FMI’s study on the injectable benzodiazepines market offers information divided into three important segments— drug class, indication, time of action, distribution channel, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Drug Class

Diazepam
Lorazepam
Midazolam

Time of Action

Short Acting
Long Acting

Indication

Agitation & Aggression
Anxiety
Alcohol Withdrawal
Muscle Spasm
Seizures
Tetanus
Sedation
Anesthesia
Insomnia
Status Epilepticus

Distribution Channel

Hospital
Ambulatory Surgical centers
Diagnostics Centers

Author

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Global Guidewires Market Set to Reach USD 5.9 Billion by 2030 at a 6.1% of CAGR

The global guidewires market is on track for substantial growth, according to recent analysis. The market is estimated to have reached a value of approximately USD 3.7 billion in 2022 and is forecasted to experience a robust compound annual growth rate (CAGR) of 6.1% from 2022 to 2030.

This anticipated growth reflects a rising demand for guidewires, driven by advancements in medical technology, an increase in minimally invasive procedures, and a growing prevalence of chronic diseases that require advanced diagnostic and therapeutic interventions. The expansion of healthcare infrastructure and innovations in guidewire design and materials are also contributing to the market’s positive outlook.

The guidewires market is positioned to benefit from ongoing improvements in medical devices and techniques, making it a key area of interest for stakeholders, investors, and industry professionals.

The WHO Global NCD Action Plan 2015-2021 does follow on with recognition of primary role as well as responsibility of various governments regarding responding positively to challenge posed by NCDs and international co-operation for supporting national efforts.

A part of their action plan is bringing down all the NCDs listed above by at least 30% and render 80% availability of basic technologies/medications.

These include provision of guidewires to facilitate minimally-invasive surgical procedures at affordable rates in ambulatory centres. These factors have been collectively driving the guidewires market till date and will continue to do so in the forecast period as well.

Plus, US FDA has come up with guidelines regarding upgradation of guidewires to ensure faster and more efficient procedures. This is another factor giving impetus to the market. This upgradation is likely to happen through inorganic as well as organic mode of expansion.

Again, as per FMI, the global guidewires market is slated to value US$ 3.3 Bn in 2022 and expected to witness a substantial CAGR of over 6.0% between 2022 and 2030.

Key Takeaways of Guidewires Market Study

The global guidewires market, in the year 2021, was dominated by interventional guidewires as they continue to be the first choice with regards to minimally-invasive surgical procedures
As far as applications are concerned, peripheral and coronary guidewires collectively account for around 65% of revenue share
By material, stainless steel, due to superior torque and ductility, is expected to be the highest revenue generator in the forecast period.
North America is expected to be the most lucrative region and expected to generate around 40% of the overall revenue in 2022 and this trend is expected to continue during the forecast period.

“Technological advancements such as the development of multifunctional and low-cost guidewires are expected to provide an innovative paradigm shift to market players.” Says the FMI Analyst.

New Product Launches – The Win-Win Strategy for Market Players

The market players are focusing on launching advanced products for supporting clinicians with respect to interventional or diagnostic procedures. For instance – Olympus Corporation, in May 2021, tabled RevoWave endoscopic guidewire in the U.S. for performing balloon dilation, biliary endoscopy, and stent placement.

On the similar grounds, Abbott’s Frontline Workhorse guidewires are making ways for most interventional devices.

What else is in the report?

Future Market Insights offers actionable insights and unique perspective on guidewires market in its latest study, presenting historical demand assessment from 2015 – 2021 and projections from 2022–2030 based on product type (interventional guidewires and diagnostic guidewires), by application (coronary guidewires, peripheral guidewires, urology guidewires, radiology guidewires, neurovascular guidewires, gastroenterology guidewires and others) by material type (Nitinol guidewires, PTFE guidewires, stainless steel guidewires and hybrid guidewires) by tip shape (J tip, angled tip and straight tip) by end-user (hospitals, ambulatory surgical centres, cardiac catheterization laboratories and speciality clinics) in seven key regions.

A Old Full Report Analysis Click Here

Key Market Segments Covered In Guidewires Industry ResearchBy Product :

Interventional Guidewires
- Hydrophilic Guidewires
- Hydrophobic Guidewires
Diagnostic Guidewires
- Hydrophilic Guidewires
- Hydrophobic Guidewires

By Application :

Coronary Guidewires
Peripheral Guidewires
Urology Guidewires
Radiology Guidewires
Neurovascular Guidewires
Gastroenterology Guidewires
Others

By Material Type :

Nitinol Guidewires
PTFE Guidewires
Stainless Steel Guidewires
Hybrid Guidewires

By Tip Shape :

J Tip
Angled Tip
Straight Tip

By End User :

Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Laboratories
Specialty Clinics

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Swab and Viral Transport Medium Market Expected to Reach USD 15.60 Billion by 2033 at a 5.8% of CAGR

Future Market Insights (FMI) has released a new analysis revealing promising growth for the global swab and viral transport medium market. According to FMI’s market attractiveness analysis, the global market is projected to reach approximately USD 8.86 billion by the end of 2023. The market is anticipated to grow at a robust compound annual growth rate (CAGR) of 5.8%, surpassing USD 15.60 billion by 2033.

This significant growth trajectory underscores the increasing demand for swab and viral transport mediums, driven by their crucial role in diagnostic testing and disease management. The rise in global health initiatives, heightened awareness of infectious diseases, and advancements in diagnostic technologies are key factors contributing to this market expansion.

The analysis highlights the evolving needs of healthcare providers and the growing emphasis on accurate and efficient testing processes. As the market evolves, stakeholders and industry players are presented with substantial opportunities for growth and innovation.

Companies in the swab and viral transport medium business are producing inventive kits with vials, double-ended flocked swabs, medications, and other items that avoid bacterial or fungal contamination. They are concentrating on a better solution formulation to stop the growth of bacterial and fungal flora. The market is expanding owing to new viral transport medium solutions.

An additional element fueling the market expansion is the rise in the number of novel viruses that have the potential to infect humans and cause a variety of illnesses. According to an article in Nature from 2021, certain respiratory viruses are resurfacing in unexpected ways as pandemic limitations loosen. Infections with the respiratory syncytial virus (RSV), which accounts for 5% of all pediatric fatalities globally, began to rise in April 2021. As a result of the increased need for specimen collection kits and diagnosis, the prevalence of additional infectious illnesses is predicted to propel market expansion.

Manufacturers are creating viral transport mediums for influenza diagnostics as the flu season gets underway. Healthcare in western nations is extremely concerned about influenza-related morbidity and death. To provide swabs and viral transport mediums, manufacturers are expanding their research and development capabilities. Manufacturers are also starting to recognize the advantages of online pharmacies over hospitals and retail pharmacies. To increase their revenue sources, they are working with established e-Commerce companies.

Owing to its highly developed medical infrastructure and high frequency of infectious illnesses, North America is predicted to dominate the global market during the forecast period. During the pandemic, North America saw a spike in laboratory testing, which fueled the market expansion. The market is also growing significantly due to the existence of biopharma businesses, a large number of labs, and research studies on viral infection.

Key Takeaways

The market in the United Kingdom is anticipated to rise, exhibiting a CAGR of 9%through 2033.
The United States is expected to develop at a1%CAGR during the forecast period.
With a CAGR of 0%over the forecast period, Canada is predicted to develop promptly in the market.
In China, the market is expected to proliferate, registering a CAGR of 7%over the forecast period.
Germany is estimated to grow decently registering a CAGR of 7% until 2033.

Competitive Landscape

Top players operating in the swab and viral transport medium market are McKesson Corporation, Cardinal Health Inc., Becton, Dickinson and Company, Thermo Fisher Scientific Inc., Quidel Corporation, COPAN Diagnostics Inc., VIRCELL S.L., Deltalab, Titan Biotech Ltd., Medical Wire & Equipment, and others.

These market players are always inventing and creating new products to suit the various requirements of diagnostic laboratories and research institutions. They are enhancing the design and components used in swabs to enhance their collection efficacy. They are also developing transport mediums that can hold viral specimens for extended periods without compromising their vitality. Additionally, to improve the stability and accuracy of diagnostic samples, they are also combining advanced technologies.

Recent Developments

In June 2022, the start of long-distance drone deliveries in North Carolina was announced by Zipline and Cardinal Health.
In May 2020, in several pharmacies across the United States, Health Mart® pharmacies announced that they would provide free COVID-19 test collection. Health Mart is dedicated to creating cutting-edge public and private collaborations as a member of the McKesson Corporation to assist address the COVID-19 epidemic.

Other Key Players Operating in the Swab and Viral Transport Market

Thermo Fisher Scientific Inc.,
Quidel Corporation,
COPAN Diagnostics Inc.,
VIRCELL S.L., Deltalab,
Titan Biotech Ltd.,
Medical Wire & Equipment

Swab and Viral Transport Medium Market by Category

By Product:

Viral Transport Medium
- Tissue Culture Medium
- Glycerol Transport Medium
Virus Swabs
- Nasopharyngeal Swabs
- Deep Nasal Swabs
- Combined Nasal & Throat Swabs
- Culture Swabs
- Vaginal Swabs

By Application:

Influenza
Respiratory syncytial virus
Mumps Virus
Adenovirus
Rhinovirus
Herpes Simplex Virus
Varicella-Zoster Virus
Other Indication

By End User:

Hospitals & ASCs
Specialty Clinics
Diagnostic Laboratories
Others

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Eye Infections Treatment Market Set for Steady Growth USD 9.9 Billion by 2030 at a 3.8% of CAGR

The global Eye Infections Treatment Market is on track for steady growth, with revenue reaching an estimated USD 7.3 billion in 2022. According to recent market analysis, the sector is projected to expand at a compound annual growth rate (CAGR) of 3.8% from 2022 to 2030. By the end of the forecast period, the market is expected to attain a valuation of approximately USD 9.9 billion.

The projected growth reflects a rising demand for advanced treatments and therapies for eye infections, driven by increasing incidences of ocular diseases, advancements in medical technologies, and growing awareness about eye health. The market expansion is supported by ongoing research and development efforts aimed at enhancing the effectiveness and accessibility of treatments.

This upward trajectory highlights the importance of continued innovation and investment in the eye infections treatment sector, offering significant opportunities for healthcare providers, pharmaceutical companies, and investors alike.

Key Takeaways of Eye Infection Treatment Market Study

Antibiotics would contribute over 55% of revenue share in the eye infection treatment market owing to their use in treating primary eye infections and post-surgical eye infections.
Eye drop sales capture over 60% market share in the eye infection treatment market.
Conjunctivitis would account for a third of eye infection treatment demand through 2030.
Bacterial infections continue to account for over 3/5^th market share.
Hospitals and retail pharmacies collectively generate over 70% of total returns to shareholders.
The increasing rate of eye surgeries and rising usage of contact lenses continue to push the North American market. European market would be upheld by the expanding geriatric pool.

Demand for eye infection treatment will continue to receive a strong impetus from increasing awareness about different eye infection types and availability of treatment, further complemented by technological advancements on ophthalmology.

Development and Licensing Deals with Multiple Commercialization Partners

Technology developers are laying greater emphasis on developing of novel ophthalmic formulation technologies and engaging with commercialization partners with licensing-out proprietary ophthalmic technologies.

For instance, Nicox S.A. has licensed out ZERVIATE (cetirizine ophthalmic solution) 0.24% to Eyevance Pharmaceuticals LLC for commercialization of ZERVIATE in the US. ZERVIATE is the first topical ocular formulation of antihistamine cetirizine approved for treatment of ocular itching associated with allergic conjunctivitis. In addition, Ocumension Therapeutics is responsible for all development and commercialization activities in Chinese market for ZERVIATE.

Demand for Eye Infection Drugs to Slump Amidst COVID-19 Pandemic

The coronavirus (COVID-19) pandemic has resulted in widened gap between supply and demand of eye infection treatments. As such, it has significantly reduced ocular surgery rate for short-term basis and, in turn, post-operative eye infections.

According to World Health Organization (WHO), national healthcare resources redirection and utilization to contain COVID-19 pandemic is expected to delay and reschedule the treatment of non-critical healthcare conditions for brief period, including eye care services, and ocular surgeries.

Know More About FMI’s Global Eye Infections Treatment Industry Study

Eye infection treatment market, a new study from Future Market Insights, opines on eye infections treatment from 2015 – 2021 and presents demand projections from 2022 – 2030 on the basis of; drug class (antibiotics, antivirals, antifungals, antihistamines, corticosteroids, and glucocorticoids), dosage form (tablet, capsule, ophthalmic ointment, and eye drops), indication (conjunctivitis, keratitis, endophthalmitis, blepharitis, stye or sty (hordeolum), uveitis, cellulitis, and ocular herpes), causative agent (virus, bacteria, fungus, and allergens) and distribution channel (hospital pharmacies, retail pharmacies, online pharmacies, and drug stores) across seven prominent regions.

A Old Full Report Analysis Click Here

Key Segments of Global Eye Infections Treatment Industry Survey By Drug Class:

Antibiotics
- Sulfonamides
- Macrolides
- Erythromycin
- Chloramphenicol
- Aminoglycosides
- Fluoroquinolones
- Vancomycin
- Tetracyclines
Antivirals
- Thymidine-Based Nucleoside Analogues (Trifluridine)
- Thymidine Phosphorylase Inhibitors (Trifluridine)
- Acyclic Nucleoside Analogue of 2’Deoxyguanasine (Ganciclovir)
- Acyclic Guanine Nucleoside Analog (Acyclovir)
- Others
Antifungals
- Polyenes (Amphotericin B (AMB) And Natamycin (NTM))
- Azoles (Miconazole (MCZ), Econazole (ECZ) And Ketoconazole (KCZ))
- Pyrimidines
- Echinocandins (Caspofungin (CFG) and Micafungin (MFG))
- Others
Antihistamines
Corticosteroids
Glucocorticoids

By Dosage Form:

Eye Infections Treatment Tablets
Eye Infections Treatment Capsules
Eye Infections Treatment Ophthalmic Ointments
Eye Infections Treatment Eye Drops
Others

By Indication:

Eye Infections Treatment for Conjunctivitis
Eye Infections Treatment for Keratitis
Eye Infections Treatment for Endophthalmitis
Eye Infections Treatment for Blepharitis
Eye Infections Treatment for Stye or Sty (Hordeolum)
Eye Infections Treatment for Uveitis
Eye Infections Treatment for Cellulitis
Eye Infections Treatment for Ocular Herpes

By Causative Agent:

Virus
Bacteria
Fungus
Allergens

By Distribution Channels:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Global Medical Ventilators Market Poised for Significant Growth, USD 4 Billion by 2033 at a 9.1% of CAGR

Future Market Insights (FMI) has unveiled its latest market research, revealing a robust growth trajectory for the global medical ventilators market. According to the research, the market is projected to reach a valuation of approximately USD 1.7 billion in 2023 and is anticipated to expand at a remarkable compound annual growth rate (CAGR) of 9.1% from 2023 to 2033.

By 2033, the medical ventilators market is expected to exceed USD 4 billion, driven by increasing healthcare needs and advancements in medical technology. This growth is reflective of the rising demand for advanced respiratory support systems due to a variety of factors including the growing prevalence of chronic respiratory diseases, the impact of global health crises, and ongoing technological innovations.

The impact of the COVID-19 pandemic has further accelerated market growth. As a result of viral infections, many patients have required ventilator support. In response, governments around the world have made significant investments in medical ventilator procurement. For instance, in April 2020, the United States government entered into a US$ 1.1 billion contract with General Health and Philips to bolster ventilator supplies. Additionally, in the same month, the United Kingdom secured 300 new ventilators from China.

The market has been witnessing technological advancements of late. The manufacturers have been enhancing the ventilators with sensors. This would ensure almost no interference from human beings. Thus, the human resource can be streamlined and directed to other important areas of the business.

The surging geriatric population across the globe is also expected to surge the sales of medical ventilators. This age group is prone to almost any kind of ailment, especially respiratory issues and cancer cases.

Thus, the FMI analysts believe that, ‘rapid urbanisation, COVID-19 pandemic, technological advancements, and a lot of other factors are expected to propel the medical ventilators market growth during the forecast period.’

Medical Ventilators Market Key Takeaways:

The market is expected to record a growth rate of 9.1%.
In 2023, the market valuation is expected to be at US$ 1.7 billion.
By 2033, the market value is expected to surpass US$ 4 billion.
As per the regional analysis, North America is expected to be the largest market.
The United States market is expected to grow at 6.8%.
The United Kingdom market is projected to advance at 5.8%.
China’s market is anticipated to surge by 14.7%.
Japan’s market is expected to advance at 9.1%.
The South Korean market is anticipated to grow at 8%.
Based on product type, critical care ventilators are expected to be the leading segment and may surge at 8.6%.
Based on application, invasive ventilators are projected to be the dominant segment and are expected to grow at 7.5%.
Based on the end user, the hospital segment is expected to be the leading segment.

Medical Ventilators Market Competitive Landscape

The key players operating in the medical ventilators market are focusing on product innovation. On that basis, they are looking to integrate their products with the latest microprocessors. There are also huge investments being made in Research and Development, to create the best quality ventilators. The manufacturers are also investing in tactical mergers and acquisitions, to expand their market share. To achieve sustainable goals, the manufacturers are also looking to cut down greenhouse emissions and make use of eco-friendly facilities. To make new strategic moves, the key players are also roping in some of the most astute minds who have been a part of this niche for decades.

Top players in the market:

Cardinal Health
Becton Dickinson and Company
GE Healthcare

Key developments in the medical ventilators Industry:

In October 2022, new research conducted by Cardinal Health highlights rheumatologist’s increasing confidence in biosimilars.
In January 2023, Michelle Quinn was named as the acting General Counsel for Becton, Dickinson, and Company.

Medical Ventilators Market Segmentation

By Product:

Critical Care Ventilators
Transport Ventilators

By Application:

Invasive Ventilators
Non-invasive Ventilators

By End User:

Hospitals
Ambulatory Surgical Centers
Long-Term Care Centers
Home Care Settings

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

FMI Study States Global Automotive Wiper Blades Market Size Expected to Reach USD 8,788.3 Million by 2033, Growing at 5.9% CAGR

The global automotive wiper blades market is projected to reach a valuation of USD 4,953.9 million in 2023 and is expected to grow to USD 8,788.3 million by 2033, with a significant CAGR of 5.9% during the forecast period.

Automotive wiper blades play a critical role in ensuring driver visibility, especially during challenging weather conditions. These essential components are designed to remove rain, snow, dirt, and debris from windshields, enhancing safety and driving comfort. The market for automotive wiper blades includes the production, distribution, and sales of wiper blades for a variety of vehicles, including passenger cars, commercial vehicles, and motorcycles.

Steady growth in the market is primarily driven by increasing global vehicle production and rising demand for passenger cars. As more vehicles are manufactured and sold, the demand for replacement wiper blades grows in parallel. Additionally, stringent road safety and visibility regulations have further fueled market expansion, as automakers strive to meet these standards.

A notable trend in the market is the growing adoption of advanced features, such as rain-sensing wipers and heated wiper blades. Rain-sensing wipers automatically activate when they detect moisture on the windshield, providing added convenience for drivers. Heated wiper blades prevent ice and snow buildup, ensuring efficient performance even in extreme weather. These innovations are gaining popularity among vehicle owners, contributing to overall market growth.

Among product types, beam wiper blades are the top sellers globally, with an expected CAGR of 6.7% during the forecast period. Drivers favor beam blades due to their curved shape, multiple pressure points, streamlined design, and compatibility with various vehicle types.

The market for rear wiper blades is also growing rapidly, with a projected CAGR of 7.0%, driven by the increased production of vehicles equipped with rear wipers. The inclusion of rear wipers as standard features in hatchbacks and small SUVs, coupled with heightened safety concerns, is boosting demand for these blades.

Key Takeaways from Report:

Passenger cars generate the majority of global market demand, with the segment expected to surpass USD 2.7 billion in valuation by 2033. The rising production and sales of passenger vehicles, particularly compact cars, are key drivers of this demand.
In North America, the United States stands out as a significant market for automotive wiper blades, holding around 17.9% of the market share in 2022. Growth in the U.S. market is fueled by increased vehicle production, advancements in wiper technology, and the popularity of SUVs.
China’s automotive wiper blades market is expected to thrive at a CAGR of 6.1%, creating incremental opportunities worth USD 1.1 billion by 2033. The country’s booming automotive industry, availability of affordable wiper blades, and a large number of automotive parts manufacturers are driving this growth.
Germany’s automotive wiper blades market is projected to grow at a moderate CAGR of 5.4%. The country’s strong automotive industry, engineering expertise, and reputation for innovation in wiper systems are key factors contributing to market expansion.

Key Companies Profiled:

Denso Corporation
Valeo SA
TRICO Products Corp.
Robert Bosch GmbH
Continental AG
HEYNER GmbH
Doga SA
ITW
Hella KGaA Hueck & Co.
Tokai Riki Co. Ltd.
Xiong Shun Automobile Material Co. Ltd.
Pilot Automotive
Fu-Gang Co. Ltd.
PSV Wipers Limited
ACDelco
Cap Co. Ltd. (CAPCO)
WEXCO Industries Inc.
Tex Automotive Ltd
Syndicate Wiper Systems (P) Ltd.
Michelin Group
Korea Wiper Blade
KB Wiper Systems

Key Segments Covered in the Automotive Wiper Blades Industry Report:

By Wiper Blades Type:

Soft Top
Hard Top

By Material:

Foam-backed Cloth
Cotton-napped Cloth
Synthetic Cloth
Perforated Cloth

By Vehicle Type:

Passenger Car
Light Commercial Vehicle
Heavy Commercial Vehicle

By Sales Channel:

Hard Top
Soft Top

By Region:

North America
Latin America
Western Europe
Eastern Europe
Asia Pacific Excluding Japan (APEJ)
Japan
The Middle East & Africa (MEA)

Access Report Details for More In-Depth Information!

Author:

Nikhil Kaitwade (Associate Vice President at Future Market Insights, Inc.) has over a decade of experience in market research and business consulting. He has successfully delivered 1500+ client assignments, predominantly in Automotive, Chemicals, Industrial Equipment, Oil & Gas, and Service industries.

His core competency circles around developing research methodology, creating a unique analysis framework, statistical data models for pricing analysis, competition mapping, and market feasibility analysis. His expertise also extends wide and beyond analysis, advising clients on identifying growth potential in established and niche market segments, investment/divestment decisions, and market entry decision-making.

Nikhil holds an MBA degree in Marketing and IT and a Graduate in Mechanical Engineering. Nikhil has authored several publications and quoted in journals like EMS Now, EPR Magazine, and EE Times.

About Future Market Insights (FMI)

Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Mobile Car Wash & Detailing Market Revenue Share to Exceed USD 251.583 Billion Mark by 2033, Expanding at a Decent 9% CAGR

The global mobile car wash & detailing market is revving up for a remarkable journey, projected to soar to a staggering USD 251.583 Billion by 2033, boasting a robust CAGR of 9% from 2023 to 2033. This impressive growth trajectory highlights the increasing demand for convenient and professional car cleaning services that come directly to the customer’s doorstep. With busy lifestyles and a growing preference for convenience, mobile car wash and detailing services offer a practical solution for maintaining vehicles in pristine condition without the hassle of traditional car wash facilities.

As the market continues to expand, fueled by urbanization, rising disposable incomes, and a growing awareness of the importance of vehicle maintenance, entrepreneurs and investors are poised to capitalize on this lucrative opportunity.

Anticipated increases in environmental regulations, which restrict household car cleaning methods, are to accelerate a greater demand for professional car wash services. One of the key reasons boosting the mobile car wash & detailing industry is the rising customer interest in car maintenance. The mobile car wash & detailing players are putting more emphasis on e-tailing due to the popularity of online shopping expanding due to its ease and flexibility.

The mobile car wash & detailing industry is seeing a considerable increase in income due to the implementation of cutting-edge technology, especially automated car wash systems. These advanced technologies give quick and effective car washing services by utilizing cutting-edge sensors and artificial intelligence, essential for the mobile car wash & detailing market expansion.

The rising demand for high-end car washing and detailing services is a significant driver escalating the mobile car wash & detailing industry to a rise in revenue. Customers are increasingly willing to spend money on professional auto cleaning and detailing services that take meticulous care of their vehicles. The trend towards premium services is picking up steam as people place more importance on maintaining the appearance and value of their automobiles and want speedy and practical fixes.

Key Takeaways from the Mobile Car Wash & Detailing Market Report:

The United States might increase its market share by 19.3% between 2023 and 2033.
Australia to hold a 0.7% share of the mobile car wash & detailing market from 2023 to 2033.
Between 2023 and 2033, Germany may hold 5.2% of the mobile car wash & detailing industry.
From 2023 to 2033, the United Kingdom mobile car wash & detailing industry registered an 8.6% CAGR.
Japan’s mobile car wash & detailing industry share could reach 4.7% between 2023 and 2033.
During the forecast period, the Chinese mobile car wash & detailing business to expand at a CAGR of 9.3%.
Through 2033, the Indian mobile car wash & detailing market is set to record a CAGR of 8.8%.
The basic segment to grab a substantial market share of 43.7% in the type category between 2023 and 2033.
The tunnels segment to grab a significant market share of 59.4% in the method category between 2023 and 2033.

Competitive Landscape:

The mobile car wash & detailing business is extremely competitive, with a variety of brands and models offered at various pricing points. Spiffy, Inc., MobileWash, Cozicars, and GoWashMyCar Ltd. are a few of the top companies on the market. To increase their market position, these businesses concentrate on research and development and work to create novel services with extra features.

Key Players in the Industry:

CARCLENX
NuWash
Mobile Car Wash
Get Spiffy Inc.
Doorstepwash
Washer
Immaculate Car detailing
Volvo Car Mobile Wash
Detailing Group
Wash Tub Car Wash

Mobile Car Wash & Detailing Market Segmentation:

By Type:

Basic
Deluxe
Premium

By Method:

Tunnels
Rollover or In-Bay
Others

By Booking:

Online
Offline

By Payment:

Cash
Cashless

By Region:

North America
Latin America
Europe
East Asia
South Asia
Oceania
The Middle East and Africa

Access Report Details for More In-Depth Information!

Author:

Nikhil holds an MBA degree in Marketing and IT and a Graduate in Mechanical Engineering. Nikhil has authored several publications and quoted in journals like EMS Now, EPR Magazine, and EE Times.

About Future Market Insights (FMI)

Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

FMI Analysis States Global Automotive ECU Market Valuation to Reach USD 22.8 Billion Milestone by 2033, Growing Steadily at 4.7% CAGR

The global automotive ECU market is projected to grow at a CAGR of 4.7% over the forecast period, reaching a market value of USD 22.8 billion by 2033, up from USD 14.4 billion in 2023.

The rising demand for automotive ECUs is driven by stricter safety regulations, increased sales of passenger vehicles, and growing per capita income. The expansion of the automotive industry has also encouraged manufacturers to incorporate ECU systems into advanced vehicles. The integration of AI and Machine Learning with ECU circuits enhances passenger convenience and provides access to a wide range of applications, including climate control, engine management, and cruise control.

Additionally, connecting car control systems to smartphones via dedicated apps improves the driving experience and expands the functionality of ECU interfaces, further fueling market growth.

Key Points:

The Chinese market for automotive ECU holds the biggest market share and is expected to cross the biggest anticipated values of US$ 5.7 Bn by 2033 with a CAGR of 5.4%. The growth rate is rising for the Chinese market as the market thrived at a lower CAGR of 3.0% between 2017 and 2022.
The Indian market for automotive ECU thrives at the highest CAGR of 6.6% during the forecast period while expecting revenue of US$ 895.9 Mn by 2033. The regional market flourished at an extremely lower CAGR of 0.7% during the previous forecast period.
The research report of FMI states that the gasoline ECU segment continues to lead the product type category with a CAGR of 5.3% between 2023 and 2033. The growth is attributed to the higher number of passenger car sales.
Based on the sales channel, the OEM segment thrives at a CAGR of 5.7% between 2023 and 2033 due to the higher amount of customer trust and better implementation.

Competitive Landscape:

The major players in the automotive ECU market focus on creating machines and software that save a higher amount of fuel and provide a healthy equation to the engine. Automotive ECU manufacturers are setting up collaborations with other companies and launching new products in the ECU market.

The market has been described as consolidated. Some of the leading market participants included in this report are:

Continental AG, Denso Corporation, Garmin Ltd., Harman International, Infineon Technologies AG, Robert Bosch GmbH, Delphi Technologies, Mitsubishi Electric Corporation, Johnson Electric Holdings Limited, Texas Instruments Incorporated, Panasonic, Aptiv, Verizon, Intel Corporation, Renesas Electronics Corporation, Microsoft Corporation, Kontron AG, ARM Limited, Fujitsu Limited, Microchip Technology Inc., Xilinx, STMicroelectronics, Sierra Wireless,, Zhuhai ENPOWER Electric Co., Intellias Ltd,, HYUNDAI MOBIS, Lear, Hitachi Astemo, Ltd., Marelli Holdings Co., Ltd., BorgWarner Inc.

For instance:

In October 2021, BorgWarner Inc. purchased Delphi Technologies. BorgWarner’s power electronic products, and electronic control unit will be strengthened as a result of the acquisition.
In February 2021, Magna announced to launch of the 3D surround view with next-generation cameras and automotive electronic control units. Driver assistance technology is mainly installed in high-end models. Now, it will be available starting with the model year 2022 and expanding across multiple customers and vehicle platforms.
In January 2021, Panasonic, plans to integrate its latest advances in optics, volume optimization, and imaging technology with A.I. from its SPYDR domain controller. Further, this renders near-filed and far-field content for vehicle information, object and pedestrian detection, and mapping for a more seamless experience for the driver.

Key Segmentations:

By Product Type:

Gasoline ECU
Diesel ECU
Natural Gas ECU

By Vehicle Type:

Passenger Vehicle
Light Commercial Vehicle
Heavy Vehicle

By Sales Channel:

OEM
Aftermarket

By Region:

North America
Latin America
Europe
Asia-Pacific
Middle East & Africa

Access Report Details for More In-Depth Information!

Author:

Nikhil holds an MBA degree in Marketing and IT and a Graduate in Mechanical Engineering. Nikhil has authored several publications and quoted in journals like EMS Now, EPR Magazine, and EE Times.

About Future Market Insights (FMI)

Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube